Quarterly report [Sections 13 or 15(d)]

Significant Balance Sheet Components

v3.25.1
Significant Balance Sheet Components
3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Significant Balance Sheet Components

NOTE 3 — Significant Balance Sheet Components

 

The following table presents the components of the Company’s accounts receivable, net:

 

   

March 31,

2025

   

December 31,

2024

 
Trade receivables   $ 7,555     $ 6,906  
Allowance for credit losses     (2,706 )     (2,567 )
Total accounts receivable   $ 4,849     $ 4,339  

 

As of January 1, 2024, accounts receivable, net, was $25,304 and non-trade receivables was $961.

 

The Company has non-trade receivables from manufacturing vendors resulting from the sale of components to the vendors who manufacture and assemble final products for the Company.

 

The Company determines the probability of default for each pool of receivables with similar risk characteristics. The probability of loss is applied to the value of the receivables and an allowance for potential credit losses is recorded with the offset to credit loss expense.

 

One customer accounts for 23% and 33%, respectively, of accounts receivable, net, at March 31, 2025, and December 31, 2024. Four additional customers account for 17%, 14%, 12%, and 11% of accounts receivable, net, at March 31, 2025. Two additional customers account for 24% and 12% of accounts receivable, net, at December 31, 2024.

 

In October 2023, the Company stopped sales of the white label products to its customer as the product reached the end of its life cycle. In February 2024, an agreement was executed that transferred $11,308 of the receivables to the manufacturer of the white label products in exchange for relieving the Company of a $11,308 accounts payable liability.

 

 

The following table presents the components of the Company’s inventory:

 

   

March 31,

2025

   

December 31,

2024

 
Devices – for resale   $ 3,904     $ 4,633  
Raw materials     4,305       5,598  
Accessories     411       390  
Inventory, net   $ 8,620     $ 10,621  

 

For certain new products, the Company began purchasing raw materials in 2024 that will be used by the third-party manufacturers to build the products. These purchased parts represent most of the raw materials in inventory at March 31, 2025 and December 31, 2024.

 

The following table presents the components of the Company’s prepaid expenses and other current assets:

 

    March 31,
2025
   

December 31,

2024

 
Deposits for inventory   $ 2,805     $ 2,697  
Other     1,913       1,865  
Prepaid expenses and other current assets   $ 4,718     $ 4,562  

 

The following table presents the components of the Company’s accrued liabilities:

 

   

March 31,

2025

   

December 31,

2024

 
Customer allowances   $ 5,355     $ 11,421  
Contract fulfillment liabilities     3,205       2,939  
Inventory received, not billed     2,037       1,563  
Employee-related liabilities     2,024       2,247  
Other     2,497       2,722  
Accrued liabilities   $ 15,118     $ 20,892  

 

Receivables Financing Agreement

 

On September 23, 2024, the Company entered into an invoice purchase agreement (the “Receivables Financing Agreement”) with LS DE LLC (“LS”), pursuant to which LS will provide receivables factoring to the Company. Pursuant to the terms of the Receivables Financing Agreement, LS will advance 80% of the face value of the receivables being sold by the Company, up to a maximum of $2,500 of eligible customer invoices from the Company. In consideration of the advances, LS is entitled to receive (i) an invoice purchase fee equal to 0.20% of the face amount of each purchased invoice payable at the time of the purchase and (ii) a daily funds usage fee equal to 0.0388%, payable monthly in arrears on the last day of each month. Under the agreement, the Company must repurchase any invoices that LS deems to be uncollectible or no longer qualify as an Eligible Account, as defined in the Receivables Financing Agreement. The Company is accounting for this transaction as a secured borrowing and recognizes a factoring liability for any advances until the accounts receivables are collected. As of March 31, 2025, and December 31, 2024, there was $642 and $591, respectively, outstanding under the Receivables Financing Agreement, which is included in Accrued Liabilities in the Condensed Consolidated Balance Sheets.

 

The Receivables Financing Agreement has an initial term of twelve months, subject to automatic annual extension unless terminated. Additionally, under certain circumstances and unless waived by LS, the Company will be obligated to pay a missing notation fee of 15% in the event of its failure to affix a certain legend regarding assignment or a misdirected payment fee in the amount of 15%. In the event of the Company’s default, the Company’s payment obligations will be accelerated, and, in addition to the aforementioned fees payable to LS, the Company will be required to pay the default interest rate of the lesser of 24% per annum or the maximum rate permitted by law until the default is cured or until all Company’s obligations are paid in full.

 

The Company’s obligations under the Receivables Financing Agreement are secured by a lien on all of the Company’s accounts receivable, inventory, and related property, excluding accounts receivable from certain specified counterparties.

 

The Receivables Financing Agreement contains representations and warranties by the Company and LS, certain indemnification provisions in favor of LS and customary covenants (including limitations on other debt, liens, acquisitions, investments and dividends), and events of default (including payment defaults, breaches of covenants, a material impairment in LS’s security interest or in the collateral, and events relating to bankruptcy or insolvency). The Receivables Financing Agreement can be terminated by either party upon written notice or by LS upon the occurrence of certain events including the Company’s default.